Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study

Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study

Zhitao Chen,1,* Yahui He,2,* Chenchen Ding,3 Jun Chen,2 Yangjun Gu,1 Min Xiao,1 Qiyong Li1 1Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310003, People’s Republic of China; 2S...

Full description

Bibliographic Details
Main Authors: Chen Z, He Y, Ding C, Chen J, Gu Y, Xiao M, Li Q
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:OncoTargets and Therapy
Subjects:
pancreatic cancer
immune checkpoint inhibitors
pd-1
gemcitabine
nab-paclitaxel
chemotherapy
Online Access:https://www.dovepress.com/safety-and-efficacy-analysis-of-pd-1-inhibitors-in-combination-with-ge-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/safety-and-efficacy-analysis-of-pd-1-inhibitors-in-combination-with-ge-peer-reviewed-fulltext-article-OTT

Similar Items